Formosa Pharmaceuticals Profit Margin

The latest profit margin for 6838.TWO is -106.92% as of March 2026. That compares with -1376.4% in the prior-year period — up 92.2% year over year. That is below the Healthcare sector average of 10.58%. Investors often review this figure alongside Formosa Pharmaceuticals's historical trend and sector peers before judging valuation or financial health.

Over the past year, 6838.TWO's profit margin moved from -1376.4% to -106.92% — a 92.2% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Formosa Pharmaceuticals's valuation or profitability profile.

Against Healthcare companies, 6838.TWO currently prints -106.92% for profit margin, while the sector average sits near 10.58%. That is roughly 1110.6% below the sector mean. Large gaps often invite a closer look at Formosa Pharmaceuticals's growth, margins, and balance sheet.

Profit Margin shows how effectively Formosa Pharmaceuticals converts resources into returns. At -106.92%, 6838.TWO may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -1376.4% in the prior-year period — up 92.2% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting 6838.TWO's profit margin (-106.92%), review year-over-year change from -1376.4%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.